Allarity Therapeutics Inc. (NASDAQ: ALLR) is -97.16% lower on its value in year-to-date trading and has touched a low of $0.28 and a high of $118.30 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ALLR stock was last observed hovering at around $0.28 in the last trading session, with the day’s gains setting it 0.01% off its average median price target of $8.00 for the next 12 months. It is also 96.38% off the consensus price target high of $8.00 offered by 1 analysts, but current levels are 96.38% higher than the price target low of $8.00 for the same period.
Currently trading at $0.29, the stock is -23.98% and -79.52% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.61 million and changing 2.46% at the moment leaves the stock -98.22% off its SMA200. ALLR registered -99.65% loss for a year compared to 6-month loss of -97.86%. The firm has a 200-day simple moving average (SMA200) of -$0.47.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
The stock witnessed a -39.00% gain in the last 1 month and extending the period to 3 months gives it a -95.61%, and is -15.36% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.28% over the week and 12.62% over the month.
Distance from 52-week low is 4.29% and -99.75% from its 52-week high.
Allarity Therapeutics Inc. (ALLR) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Allarity Therapeutics Inc. (ALLR) is a “Hold”. 1 analysts offering their recommendations for the stock have an average rating of 3.00, where 1 rate it as a Hold and 0 think it is a “Overweight”. 0 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
Allarity Therapeutics Inc. is expected to release its quarterly report on 10/10/2023.The EPS is expected to grow by 47.30% this year
Allarity Therapeutics Inc. (ALLR) Top Institutional Holders
The shares outstanding are 0.76M, and float is at 0.24M with Short Float at 69.95%.
